Citations

Showing 10 of 108152 citations.

Generational Differences in Grit, Self-Control, and Conscientiousness Among Orthopaedic Surgeons
Samuelsen, Brian T. , Desai, Vishal S. , Turner, Norman S. , Kelly, Anne M. , Grawe, Brian M. , Camp, Christopher L. , Camp, Christopher L. , Desai, Vishal

Mayo Clinic

Journal of Bone and Joint Surgery | July 18, 2019 | Volume: 101 | Issue: 14 | Pages: e71

10.2106/jbjs.18.00275 | PMID 31318816 Get It

Background: The training process and practice of orthopaedic surgery is demanding and arduous. Accordingly, grit, self-control, and conscientiousness are desirable qualities in orthopaedic surgeons. Some established orthopaedists have expressed concern that the future generation of surgeons may not possess the same level of grit as their predecessors. The purpose of this study was to evaluate levels of grit among attending orthopaedic surgeons, identify predictors of grit in orthopaedic surgeons, and compare grit scores between attending surgeons and orthopaedic residency applicants. We hypothesized that applicants would demonstrate lower grit and self-control scores but greater conscientiousness scores than attending surgeons. Methods: A total of 2,342 attending orthopaedic surgeons and 895 orthopaedic residency applicants from the 2016-2017 National Resident Matching Program (NRMP) were given surveys that quantified their grit, self-control, and conscientiousness. Demographic and career information also was collected. Results: Assessments were completed by 655 (28%) of 2,342 practicing orthopaedic surgeons and 455 (50.8%) of 895 orthopaedic residency applicants. The residency applicants demonstrated higher mean grit scores (4.12 of 5.0) than the attending orthopaedic surgeons (4.03) (p < 0.01). These average scores placed applicants and attending surgeons at the 70th and 65th percentile, respectively, when compared with the general population. There were no differences in self-control (p = 0.68) or conscientiousness (p = 0.93) between the 2 groups. Attending surgeons with more publications had increased grit (p < 0.01), self-control (p = 0.04), and conscientiousness (p = 0.01) scores. Attending surgeons who had been inducted into the Alpha Omega Alpha honor society as medical students demonstrated greater conscientiousness scores than those who were not members (p = 0.04). Conclusions: Orthopaedic residency applicants were at least as gritty, consistent in their interest, persevering in their efforts, and ambitious as currently practicing orthopaedic surgeons. Although these results may be encouraging and diverge from some preconceived perceptions of “millennials,” it is unclear if they will be predictive of career success in the next generation of orthopaedists.
Loratadine for Paclitaxel-Induced Myalgias and Arthralgias
Smith, Caleb J. , Hendrickson, Andrea Wahner, Grudem, Megan E. , Klampe, Carolyn M., Deering, Erin, Jatoi, Aminah , Smith, Caleb , Grudem, Megan, Klampe, Carolyn

Mayo Clinic

American Journal of Hospice and Palliative Medicine® | July 18, 2019 | Volume: 37 | Issue: 3 | Pages: 235-238

10.1177/1049909119864083 | PMID 31315424 Get It

Background: Seventy percentage of patients who receive paclitaxel have diffuse, refractory myalgias, and arthralgias. Based on anecdotal reports, this study explored whether loratadine, an antihistamine, palliates these symptoms. Methods: The medical records of postoperative ovarian and patients with endometrial cancer were studied, as these patients are routinely prescribed paclitaxel. Records were screened for patients who received paclitaxel and loratadine concurrently. Results: Forty patients are the focus of this report. Eight had paclitaxel-induced myalgias and arthralgias and then took loratadine; of these, 6 (75%; 95% confidence interval: 35%, 97%) manifested evidence of symptom improvement: “She did experience some migrating generalized body aches and pains…but this has resolved.” Of those already receiving loratadine but with no myalgias and arthralgias, only 11 of 32, or 34% (95% confidence interval: 19%, 53%), developed myalgias and arthralgias (in contrast to the previously reported symptom rate of 70%). No adverse events were clearly attributed to loratadine. Conclusion: These preliminary data support further study of loratadine for paclitaxel-induced myalgias and arthralgias.
Trends and Inpatient Outcomes of Venous Thromboembolism-Related Admissions in Patients with Philadelphia-Negative Myeloproliferative Neoplasms
Katiyar, Vatsala , Uprety, Alok, Mendez-Hernandez, Andres , Andrade-Gonzalez, Xavier , Zia, Maryam, Fuentes, Harry E , Fuentes, Harry E

Mayo Clinic

TH Open | July 17, 2019 | Volume: 03 | Issue: 03 | Pages: e203-e209

10.1055/s-0039-1692988 | PMID 31321378 Get It

Background Patients with Philadelphia-negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocytosis (ET), and primary myelofibrosis (MF), have a significant risk of venous thromboembolism (VTE). We aim to determine the trends in annual rates of VTE-related admissions, associated cost, length of stay (LOS), and in-hospital mortality in patients with MPN. Methods We identified patients with PV, ET, and MF from the Nationwide Inpatient Sample (NIS) database from 2006 to 2014 using ICD-9CM coding. Hospitalizations where VTE was among the top-three diagnoses were considered VTE-related. We compared in-hospital outcomes between VTE and non-VTE hospitalizations using chi-square and Mann–Whitney U-test and used linear regression for trend analysis. Results We identified 1,046,666 admissions with a diagnosis of MPN. Patients were predominantly white (65.6%), females (52.7%), with a median age of 66 years (range: 18–108). The predominant MPN was ET (54%). There was no difference in in-hospital mortality between groups (VTE: 3.4% vs. non-VTE: 3.2%; p = 0.12); however, VTE admissions had a longer LOS (median: 6 vs. 5 days; p < 0.01) and higher cost (median: VTE US$32,239 vs. 28,403; p ≤ 0.01).The annual rate of VTE admissions decreased over time (2006: 3.94% vs. 2014: 2.43%; p ≤ 0.01), compared with non-VTE–related admissions. Conclusion In our study, VTE-related admissions had similar in-hospital mortality as compared with non-VTE–related admissions. The rates of hospitalizations due to VTE have decreased over time but are associated with a higher cost and LOS. Newer risk assessment tools may assist in preventing VTE in high-risk patients and optimizing resource utilization.
Risk of Adverse Reactions to Oral Antibiotics Prescribed by Dentists
Thornhill, Martin H. , Durkin, Michael J. , Lockhart, Peter B. , Thornhill, M H , Durkin, M J , Dayer, Mark , Baddour, Larry M.

Mayo Clinic

Journal of Dental Research | July 17, 2019 | Volume: 98 | Issue: 10 | Pages: 1081-1087

10.1177/0022034519863645 | PMID 31314998 Get It

Dentists prescribe a large portion of all oral antibiotics, and these are associated with a risk of adverse drug reactions (ADRs). The aim of this study was to quantify the risk of ADRs associated with oral antibiotics commonly prescribed by dentists. NHS Digital Prescribing data and Yellow Card Drug Analysis data for 2010 to 2017 were abstracted to quantify dental antibiotic prescribing in England, and the rate and types of ADRs associated with them. During the period of study, the mean number of actively practicing dentists in England was 23,624. Amoxicillin accounted for 64.8% of dental antibiotic prescribing and had the lowest reported rate of fatal ADRs (0.1/million prescriptions) and overall ADRs (21.5/million prescriptions). Indeed, amoxicillin was respectively 6 and 3 times less likely to cause an ADR than the other penicillins, penicillin V and amoxicillin + clavulanic acid, and appears to be very safe in patients with no history of penicillin allergy. In contrast, clindamycin, which is often used in patients with penicillin allergy, had the highest rate of fatal (2.9/million prescriptions) and overall (337.3/million prescriptions) ADRs, with Clostridiodes (formerly Clostridium) difficile infections pivotal to its ADR profile. Other amoxicillin alternatives, clarithromycin and metronidazole, while significantly worse than amoxicillin, were 3 and nearly 5 times less likely to cause an ADR than clindamycin. Ranked from least to most likely to cause an ADR, antibiotics most commonly prescribed were as follows: amoxicillin < cephalosporins < erythromycin < tetracyclines < azithromycin < metronidazole < amoxicillin + clavulanic acid < clarithromycin < penicillin V < clindamycin. This study confirmed the high level of safety associated with use of amoxicillin by dentists and the significantly worse rates of fatal and nonfatal ADRs associated with other penicillins and alternatives to amoxicillin for those who are penicillin allergic. In particular, clindamycin had the highest rate of fatal and nonfatal ADRs of any of the antibiotics commonly prescribed by dentists.
Stanniocalcin-1 is a Modifier of Oxygen-Induced Retinopathy Severity
Hartnett, M. Elizabeth , Bretz, Colin A. , Hann, Cheryl R., Cui, Ricky Z. , Marmorstein, Alan D. , Sheikh‐Hamad, David , Fautsch, Michael P. , Roddy, Gavin W. , Roddy, Gavin W , Dalvin, Lauren A. , Hartnett, M. Elizabeth , Marmorstein, Alan D

Mayo Clinic

Current Eye Research | July 17, 2019 | Volume: 45 | Issue: 1 | Pages: 46-51

10.1080/02713683.2019.1645184 | PMID 31314602 Get It

Methods for the Watch the Spot Trial. A Pragmatic Trial of More- versus Less-Intensive Strategies for Active Surveillance of Small Pulmonary Nodules
Gould, Michael K. , Kelly, Karen , Altman, Danielle, Bie, Evan de, Dyer, Debra S. , Barbosa, Eduardo J. Mortani , Qi, Lihong , Vaszar, Laszlo T. , Yu, Sophronia , Miglioretti, Diana L. , Miglioretti, Diana L , Kelly, Karen , Smith‐Bindman, Rebecca , Barjaktarević, Igor , Creekmur, Beth , Mularski, Richard A.

Mayo Clinic

Annals of the American Thoracic Society | July 17, 2019 | Volume: 16 | Issue: 12 | Pages: 1567-1576

10.1513/annalsats.201903-268sd | PMID 31314549 Get It

Abstract Small pulmonary nodules are most often managed by surveillance imaging with computed tomography (CT) of the chest, but the optimal frequency and duration of surveillance are unknown. The Watch the Spot Trial is a multicenter, pragmatic, comparative-effectiveness trial with cluster randomization by hospital or health system that compares more- versus less-intensive strategies for active surveillance of small pulmonary nodules. The study plans to enroll approximately 35,200 patients with a small pulmonary nodule that is newly detected on chest CT imaging, either incidentally or by screening. Study protocols for more- and less-intensive surveillance were adapted from published guidelines. The primary outcome is the percentage of cancerous nodules that progress beyond American Joint Committee on Cancer seventh edition stage T1a. Secondary outcomes include patient-reported anxiety and emotional distress, nodule-related health care use, radiation exposure, and adherence with the assigned surveillance protocol. Distinctive aspects of the trial include: 1) the pragmatic integration of study procedures into existing clinical workflow; 2) the use of cluster randomization by hospital or health system; 3) the implementation and evaluation of a system-level intervention for protocol-based care; 4) the use of highly efficient, technology-enabled methods to identify and (passively) enroll participants; 5) reliance on data collected as part of routine clinical care, including data from electronic health records and state cancer registries; 6) linkage with state cancer registries for complete ascertainment of the primary study outcome; and 7) intensive engagement with a diverse group of patient and nonpatient stakeholders in the design and execution of the study.
Multidisciplinary teams for cardiogenic shock
Vallabhajosyula, Saarwaani , Barsness, Gregory W. , Vallabhajosyula, Saraschandra , Vallabhajosyula, Saraschandra

Mayo Clinic

Aging | July 17, 2019 | Volume: 11 | Issue: 14 | Pages: 4774-4776

10.18632/aging.102104 | PMID 31314745 Get It

Incident atrial fibrillation in patients undergoing bariatric surgery: a systematic review and meta‐analysis
Chokesuwattanaskul, Ronpichai , Cheungpasitporn, Wisit , Sharma, Konika , Watthanasuntorn, Kanramon , Lertjitbanjong, Ploypin , Pachariyanon, Pavida , Prechawat, Somchai, Torres‐Ortiz, Aldo, Cheungpasitporn, Wisit , Chokesuwattanaskul, Ronpichai , Thongprayoon, Charat , Mao, Michael A.

Mayo Clinic

Internal Medicine Journal | July 17, 2019 | Volume: 50 | Issue: 7 | Pages: 810-817

10.1111/imj.14436 | PMID 31314166 Get It

AbstractBackgroundThere are controversial data regarding the relationship between bariatric surgery and atrial fibrillation (AF). This meta‐analysis was performed to evaluate (i) the incidence and (ii) the risk of AF in patients following bariatric surgery.AimsTo explore the incidence and risk factors of AF in patients after bariatric surgery.MethodsA literature search was conducted utilising MEDLINE, EMBASE and Cochrane Database from inception through March 2019. We included studies that evaluated the (i) incidence and (ii) risk of AF in patients after bariatric surgery. Pooled incidence and odds ratios (OR) with 95% confidence interval (CI) were calculated using random effects meta‐analysis.ResultsSeven cohort studies consisting of 7681 patients undergoing bariatric surgery were enrolled in this systematic review. The prevalence of AF in patients undergoing bariatric surgery ranged between 0% and 4.6%. Overall, the pooled estimated incidence of AF following bariatric surgery was 5.3% (95% CI: 1.9–13.8) at a median follow‐up time of 7.9 years (interquartile range (IQR) 4.1–15.0 years). Compared to controls, the pooled OR of AF among patients undergoing bariatric surgery was 0.42 (95% CI: 0.22–0.83) at a median follow‐up time of 7.9 years (IQR 7.2–19.0 years). Egger regression test demonstrated no significant publication bias in our meta‐analysis of AF incidence following bariatric surgery.ConclusionThe overall estimated incidence of AF following bariatric surgery was 5.3%. Our study demonstrates a significant beneficial association between bariatric surgery and AF, with a 0.42‐fold decreased risk of AF. Future large‐scale studies are needed to confirm the potential benefits of bariatric surgery on risk of AF.